StemCyte International, Ltd. (TPE:4178)

StemCyte International Revenue

StemCyte International had revenue of 96.64M TWD in the quarter ending June 30, 2026, with 5.75% growth. This brings the company's revenue in the last twelve months to 362.99M, down -7.32% year-over-year. In the year 2025, StemCyte International had annual revenue of 368.91M, down -3.60%. That makes StemCyte International the 36,709th largest company in the world by revenue and 1,930th in Taiwan.

• Revenue (ttm): 362.99M
• Revenue Growth: -7.32%
• P/S Ratio: 11.66
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.23B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	368.91M	-13.77M	-3.60%
Dec 31, 2024	382.69M	19.91M	5.49%
Dec 31, 2023	362.78M	15.09M	4.34%
Dec 31, 2022	347.69M	-509.38M	-59.43%
Dec 31, 2013	857.07M	124.33M	16.97%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 7, 2026

Data Sources Report a data error